BMY has been in the news 346% more than usual
Apr 22, 2025, 10:31 PM
-5.62%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: Cantor Fitzgerald has initiated coverage of Eli Lilly with an overweight rating and a 12-month price target of $975, highlighting the company's strong position in the obesity market. Additionally, President Trump's executive order may extend pricing freedom for small-molecule drugs, potentially impacting Medicare spending significantly.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.